Torbjørn Omland
Professor
-
Klinikk for indremedisin og lab fag

English version of this page
Mobiltelefon
+47 40107050
+47-40107050
Brukernavn
Besøksadresse
Campus Akershus Universitetssykehus
1478 Lørenskog
Postadresse
Akershus universitetssykehus
1478 Lørenskog
Andre tilknytninger
Administrasjonen Campus Ahus
Faglige interesser
- Hjertesvikt
- Koronarsykdom
- Kardiovaskulære biomarkører
- Kardiovaskulær endokrinologi
- Kardiovaskulære effekter av kreftbehandling
- Kardiovaskulær sykdom ved KOLS og obstruktiv søvnapne
- Kardiovaskulær sykdom ved depresjon
Bakgrunn
Utdanning
- 1987 Cand. Med. Universitetet i Bergen
- 1989 Diploma in Tropical Medicine (D.T.M.), University of Copenhagen, Denmark
- 1995 Educational Commission for Foreign Medical Graduates (ECFMG) Certification
- 1996 Dr. med. Universitetet i Bergen. Avhandling: Neurohumoral Activation after Acute Myocardial Infarction: Relation to Indices of Cardiac Function and Prognosis
- 1996 Program in Clinical Effectiveness, Harvard University
- 1997 Master of Public Health (M.P.H.), Harvard School of Public Health
- 2003 Basalutdanning i universitetspedagogikk, Universitetet i Oslo
Akademiske stillinger
- 1992-1995 Universitetsstipendiat, Universitetet i Bergen
- 1995-1997 Research Fellow in Medicine, Harvard University, Cambridge, MA, USA
- 2003 Professor II (hjertemedisin), Universitetet i Oslo
- 2004 Professor I (indremedisin) – Universitetet i Oslo
- 2009 Fakultetsdivisjonsleder Akerhus Universitetssykehus
- 2010-2014 Nestleder, Institutt for klinisk medisin, Universitetet i Oslo
Priser
- 1987 F. Meltzers pris (Universitetet i Bergen).
- 1995 J. William Fulbright Award.
- 1995 Caroline Musæus Aarsvolds pris (Den norske lægeforening).
- 1996 Pris fra Overlege Dr. M.D. Johan Carl Unger Vetlesen Charitable Fund
- 2004 Ole Storsteins pris for 2004. Norsk Cardiologisk Selskap
- 2008 Fellow, European Society of Cardiology
- 2017 Fellow, American College of Cardiology
Verv
- 2016 Associate Editor, Circulation
- 2017 Editor of Chronic Coronary Artery Disease: A Companion to Braunwald’s Heart Disease, 1stedition (Elsevier 2017).
- 2017 Member, International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers
- 2017 Head, National Publication Committee for Medicine (NPU-MED), Norway
- 2017 Member National Publication Committee (NPU, Norway)
- 2017 Editorial Board, International Journal of Cardiology
- 2017 Board member, Research Council, South-Eastern Regional Health Authority, Norway
- 2016 Board member, Norwegian Clinical Research Infrastructure Network (NorCRIN)
- Member of professor evaluation committees at the University of Oslo, Norway, University of Bergen, Norway, University of Aarhus, Denmark, University of Athens, Greece, University of Texas South-Western, Dallas, USA, Karolinska Institutet, Stockholm, Sweden
- Grant reviewer European Research Council, Canadian Institutes for Health Research (CIHR), Wellcome Trust, Swiss National Science Foundation, Foundation for Polish Science, Swedish Heart-Lung Foundation Big Award, North of Norway Regional Health Authority, Deutcshe Forschungsgemeinschaft (DFG)
- Reviewer in >30 international journals, including The New England Journal of Medicine, The Lancet, JAMA, Circulation, Journal of the American College of Cardiology, Nature Biotechnology
Samarbeid
- Professor Eugene Braunwald, TIMI Study Group, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; USA.
- Professor James A de Lemos, Dallas Heart Study, University of Texas Southwestern, Dallas, TX, USA.
- Professor Ramachandran Vasan, Framingham Heart Study, Framingham, MA
- Professor Kristian Hveem, Helseundersøkelsen i Nord-Trøndelag, NTNU, Trondheim
Veiledning
- Hovedveileder for 10 fullførte PhD grader
- Medveileder for 7 fullførte PhD grader
- Veileder for 13 medisinstudentoppgaver
Utvalgte publikasjoner
- Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality following acute myocardial infarction.Circulation 1994;89:1573-1579. Times cited 328
- Omland T, Aakvaag A, Bonarjee VVS, Caidahl K, Lie RT, Nilsen DWT, Sundsfjord JA, Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation1996;93:1963-1969. Times cited: 613
- Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996;76:232-237. Times cited: 132
- Tawakol A, Omland T, Gerhard M, Wu J, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation1997,95:1119-1121. Times cited: 607
- de Lemos JA, Morrow DA, Bentley JH, Omland T, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-1021. Times cited: 949
- Omland T, Persson, Ng L, O'Brien R, Karlsson T, Herlitz J, Hartford M, Caidahl K. N-terminal pro-B-type natriuretic peptide andlong-term mortality in acute coronary syndromes.Circulation 2002; 106:2913-2918.Times cited: 463
- Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New Engl J Med 2002;347:161-167. Times cited: 2203.
- Wang T, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. Plasma natriuretic peptide levels and the risk of cardiovascular events and mortality. N Engl J Med 2004;350:655-663. Times cited: 954
- Søyseth V, Brekke PH, Smith P, Omland T. Statin use is associated with reduced mortality in chronic obstructive pulmonary disease. Eur Respir J 2007;29:279-283. Times cited: 177
- Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E. Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease. The PEACEt rial. J Am Coll Cardiol 2007;50:205-214. Times cited: 141
- Omland T, Ueland T, Jansson AM, Persson A, Karlsson T, Smith C, Herlitz J, Aukrust P, Hartford M, and Caidahl K. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. J Am Coll Cardiol 2008; (51) 6:627-633.Times cited: 151
- Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, and Braunwald E. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl JMed 2009; (361) 26:2538-2547. Times cited: 537
- de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, and McGuire DK. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010; (304) 22:2503-2512. Times cited: 552
- Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Røsjø H, Salytyte Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 2013;61:1240-1249. Times cited: 149
- Omland T. Cardiac troponins: a tool for a personalized medicine strategy in stable coronary artery disease? (Invited Editorial Comment) J Am Coll Cardiol 2014;63: 355-357.
- Omland T, de Lemos JA, Holmen OL, Dalen H, Benth JS, Nygård S, Hveem K, Røsjø H. Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population. Clin Chem 2015;61:646-656. Times cited: 30
- Gulati G, Heck SL, Ree AH, Hoffman P, Schulz-Menger J, Fagerland MW, Gravdehaug B, Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T. Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol. Eur Heart J 2016; 37: 1671-1680.Times cited: 77
- Lyngbakken MN, Skranes JB, de Lemos JA, Nygård S, Dalen H, Hveem K, Røsjø H, Omland T. Impact of smoking on Circulating cardiac troponin I concentrations and cardiovascular events in the general population: The HUNT study (Nord-Trøndelag Health Study). Circulation 2016; 134: 1962-1972.
- Omland T, Kullo IJ. Biomarker-based risk models to risk stratify patients with stable coronary heart disease. (Invited Editorial Comment) J Am Coll Cardiol 2017;70: 827-829.
- Omland T. Can Circulating BNP Concentrations Guide Treatment of Obstructive Left Main Coronary Artery Disease? (Invited Editorial Comment) Circulation 2018; 138:479-482.
Publisert 13. apr. 2011 11:42
- Sist endret 9. okt. 2018 00:04